Evidence map›Paper›PMID 22437667›Full record

ArticleCancer2012

Intraoperative detection and removal of microscopic residual sarcoma using wide-field imaging.

Jeffrey K Mito, Jorge M Ferrer, Brian E Brigman, Chang-Lung Lee, Rebecca D Dodd, William C Eward, Lisa F Marshall, Kyle C Cuneo, Jessica E Carter, Shalini Ramasunder and 5 more

Open access · bronzeAbstract readEvaluation Study
In one paragraph

Article in Cancer, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Measuring microdose ABY-029 fluorescence signal in a primary human soft-tissue sarcoma resection.Proceedings of SPIE--the International Society for Optical Engineering · 2019
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Advances in fluorescent-image guided surgery.Annals of translational medicine · 2016
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Jeffrey K MitoDepartment of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC 27708, USA.
Jorge M Ferrer
Brian E Brigman
Chang-Lung Lee
Rebecca D Dodd
William C Eward
Lisa F Marshall
Kyle C Cuneo
Jessica E Carter
Shalini Ramasunder
Yongbaek Kim
W David Lee
Linda G Griffith
Moungi G Bawendi
David G Kirsch
Duke Medical Center · USMassachusetts Institute of Technology · USDuke University · USSeoul National University · KR

Funding

Independent Scientist Award for Radiation ResearchK02AI093866 · NIAID · DUKE UNIVERSITY · PI KIRSCH, DAVID GUY · 2011 to 2015
$501k
NIAID NIH HHS K02 AI093866
6 · The paper itself

Abstract

backgroundThe goal of limb-sparing surgery for a soft tissue sarcoma of the extremity is to remove all malignant cells while preserving limb function. After initial surgery, microscopic residual disease in the tumor bed will cause a local recurrence in approximately 33% of patients with sarcoma. To help identify these patients, the authors developed an in vivo imaging system to investigate the suitability of molecular imaging for intraoperative visualization.

methodsA primary mouse model of soft tissue sarcoma and a wide field-of-view imaging device were used to investigate a series of exogenously administered, near-infrared (NIR) fluorescent probes activated by cathepsin proteases for real-time intraoperative imaging.

resultsThe authors demonstrated that exogenously administered cathepsin-activated probes can be used for image-guided surgery to identify microscopic residual NIR fluorescence in the tumor beds of mice. The presence of residual NIR fluorescence was correlated with microscopic residual sarcoma and local recurrence. The removal of residual NIR fluorescence improved local control.

conclusionsThe authors concluded that their technique has the potential to be used for intraoperative image-guided surgery to identify microscopic residual disease in patients with cancer.

Indexed as

AnimalsFluorescent DyesInfrared RaysIntraoperative PeriodMiceNeoplasm, ResidualSarcomaSarcoma, ExperimentalSoft Tissue NeoplasmsSurgery, Computer-AssistedFluorescent Dyes

Identifiers

PMID22437667
PMCPMC3532657
OpenAlexW1560056785

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.